Echogenic Amniotic Fluid on Perinatal Outcome
Clinical Significance of Echogenic Amniotic Fluid on Perinatal Outcome
1 other identifier
interventional
200
1 country
1
Brief Summary
Amniotic fluid is the liquid that surrounds a developing fetus in the amniotic sac and is usually clear to pale yellow in color. Amniotic fluid composition is complex with many maternal and fetal constituents. It is mainly formed from fetal plasma volume, fetal urine, fetal respiratory system, gastrointestinal tract, umbilical cord, and fetal surface of the placenta. The composition of the Amniotic fluid changes with the gestational age with an average pH of 7.2 and specific gravity of 1.0069-1.008
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2022
CompletedFirst Posted
Study publicly available on registry
June 7, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2023
CompletedSeptember 8, 2023
September 1, 2023
1 year
May 29, 2022
September 6, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Pregnant females with Echogenic Amniotic Fluid .
Estimation the gestational age and neonatal status.
At the time of the Delivery
Study Arms (1)
Echogenic Amniotic Fluid
OTHERestimation the nature of echogenic amniotic fluid.to overcome unnecessary intervention due to turbid amniotic fluid, assessing the neonatal outcome and estimation the gestational age at time of delivery in patients with echogenic amniotic fluid.
Interventions
To estimate the nature of echogenic amniotic fluid.and To overcome unnecessary intervention due to turbid amniotic fluid, assess neonatal outcome and estimate gestational age at time of delivery in patients with echogenic amniotic fluid.
Eligibility Criteria
You may qualify if:
- Pregnant women aged between 20, 35 years.
- Near or Full-term pregnant women admitted for delivery.
- Reliable date of LMP.
- Delivered vaginally after spontaneous onset of labor or CS.
You may not qualify if:
- Fetal congenital anomaly by ultrasound (anencephaly\& Down syndrome), IUGR or macrosomic fetuses.
- Multifetal pregnancy.
- Maternal co-morbidity (Diabetes mellitus, hypertension, cardiac diseases, renal diseases \& hemorrhagic diseases) .
- Maternal infection (Toxoplasmosis, Varicella zoster infection,…).
- Placental abnormality (abruption placenta \& placenta previa)
- Cases with normal amniotic fluid study with ultrasonography.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Egymedicalpedialead
Study Sites (1)
Al-Azhar University hospitals
Asyut, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 29, 2022
First Posted
June 7, 2022
Study Start
August 1, 2022
Primary Completion
August 1, 2023
Study Completion
August 30, 2023
Last Updated
September 8, 2023
Record last verified: 2023-09